Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127588321 | 12758832 | 1 | I | 20160822 | 20160905 | 20160919 | 20160919 | PER | JP-FRI-1000087460 | FOREST | 28.00 | YR | M | Y | 0.00000 | 20160919 | OT | US | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127588321 | 12758832 | 1 | PS | ASENAPINE | ASENAPINE | 1 | Sublingual | 10 MG | 22117 | 5 | MG | SUBLINGUAL TABLET | BID | ||||||
| 127588321 | 12758832 | 2 | SS | ASENAPINE | ASENAPINE | 1 | Sublingual | 5 MG | 22117 | 5 | MG | SUBLINGUAL TABLET | QD | ||||||
| 127588321 | 12758832 | 3 | SS | LUNESTA | ESZOPICLONE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127588321 | 12758832 | 1 | Schizophrenia |
| 127588321 | 12758832 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127588321 | 12758832 | Insomnia | |
| 127588321 | 12758832 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127588321 | 12758832 | 1 | 20160802 | 20160822 | 0 | |
| 127588321 | 12758832 | 2 | 20160823 | 0 |